M&Ms And PBMs: Sandoz CEO Talks Antibiotics And Ustekinumab

Richard Saynor Discusses ‘Offensive’ US Antibiotics Pricing And Reveals Tie-Up For Stelara Rival

 
• By Dave Wallace
  
Antibiotics cost “less than a packet of M&Ms” in the US, Saynor highlighted (Shutterstock)

More from Strategy

More from Generics Bulletin